Paul M. Beringer

Also affiliated with Keck Hospital of USC, California Southern University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI)”.

Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI)

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.09.002

N/A

0.208DataRank · unranked

3 citations

Eunjin Hong, Peter S. Chung, Adupa P. Rao, Whitaker Cohn, Paul M. Beringer +1 more

Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer

Neuro-Oncology(2021)10.1093/neuonc/noab041

N/A

0DataRank · unranked

29 citations

Haiping He, Nagore I. Marín‐Ramos, Shan Zeng, Steven Swenson, Hee‐Yeon Cho +7 more

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3705

N/A

0DataRank · unranked

9 citations

Mary Hebert, Emily Fay, G. Turner, Patricia H. Eshaghian, Aaron Trimble +4 more